MedTrace Logo

Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer

NCT00079300 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2013-04-26

No results posted yet for this study

Summary

RATIONALE: Biological therapies, such as imiquimod cream, work in different ways to stimulate the immune system and stop tumor cells from growing.

PURPOSE: This randomized phase I trial is studying how well imiquimod cream works in treating patients with basal cell skin cancer.

Conditions

  • Non-melanomatous Skin Cancer

Interventions

DRUG

imiquimod

PROCEDURE

conventional surgery

Sponsors & Collaborators

  • National Naval Medical Center

    lead FED

Principal Investigators

  • Francesco M. Marincola, MD · NIH - Warren Grant Magnuson Clinical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2005-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00079300 on ClinicalTrials.gov